FindMyRecallSubscribe
Class I: serious health riskTerminated

Baxter Healthcare Intralipid 20% Recall

Intralipid 20%, A 20% I

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class I
Reported by FDA
Nov 1, 2017
Recall ID
D-0030-2018
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Intralipid 20% starting Sep 15, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0030-2018 on Nov 1, 2017. Reason: Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility. Status: Terminated.

Why it was recalled

Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility.

Product description

Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden for Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0519-58

Lot numbers, UPCs & expiration codes

Lot #: 10LE9597, Exp 04/01/19

Where it was sold

Impacted shipment sent to Wholesalers, Medical Facilities and Physicians in CA and NV, but could have been further distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0030-2018
Classification
Class I
Status
Terminated
Recall initiated
Sep 15, 2017
FDA report date
Nov 1, 2017
Quantity
910 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-0030-2018, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
78155
Address
1 Baxter Pkwy
Code information
Lot #: 10LE9597, Exp 04/01/19
Postal code
60015-4625
Report date
Nov 1, 2017
Product type
Drugs
Recall number
D-0030-2018
Classification
Class I
Recalling firm
Baxter Healthcare Corporation
Product quantity
910 bags
Termination date
Sep 6, 2018
Reason for recall
Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden for Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0519-58
Distribution pattern
Impacted shipment sent to Wholesalers, Medical Facilities and Physicians in CA and NV, but could have been further distributed Nationwide in the USA.
Recall initiation date
Sep 15, 2017
Initial firm notification
Letter
Center classification date
Oct 24, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0030-2018, published Nov 1, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls